MedicaidCoverageMedium impact
BT202274: IHCP to reimburse HCPCS code Q0222
Indiana Medicaid (IHCP)·IN · Infectious Disease, Internal Medicine, Family Medicine +1 more·Claims & Billing
Effective date
Aug 15, 2022
We identified it
Jun 19, 2026
Summary
Indiana Medicaid (IHCP) will now reimburse HCPCS code Q0222 (bebtelovimab injection) at a maximum fee of $2,205.00 with no prior authorization required. This applies to professional and outpatient claims with dates of service on or after August 15, 2022.
Action Required
Immediately: Billing team must update system to include HCPCS code Q0222 for bebtelovimab injections with maximum reimbursement of $2,205.00 for Indiana Medicaid patients. Ensure NDC number is included when billing this code. For outpatient settings, code can be billed with revenue code 636 for separate reimbursement.